Table 2.
ICIQ-SF questionnaire. Changes from baseline after 12 months of treatment with OXY-TDS.
| ICIQ-SF questionnaire | Pretreatment patients N=47 | Posttreatment patients N=47 | p value∗∗ |
|---|---|---|---|
| n | n | ||
| No urine leaks | 2 (4.3%) | 18 (38.3%) | <0.001 |
| Leaks before you can get to the toilet | 41 (87.2%) | 22 (46.81%) | <0.001 |
| Leaks when you cough or sneeze | 18 (38.30%) | 7 (14.9%) | 0.013 |
| Leaks when you are asleep | 11 (23.4%) | 3 (6.4%) | 0.008 |
| Leaks when you are physically active/exercising | 16 (34.04%) | 7 (14.9%) | 0.035 |
| Leaks when you have finished urinating | 9 (19.15%) | 2 (4.3%) | 0.039 |
| Leaks for no obvious reason | 15 (31.91%) | 2 (4.3%) | <0.001 |
| Leaks all the time | 2 (4.25%) | 0 (0.0%) | NA |
|
| |||
| ICIQ-SF item 1 and 2 = 0 | 2 | 19 | <0.001 |
| ICIQ-SF item 1 or 2 > 0 | 45 | 27 | |
|
| |||
| ICIQ-SF = 0 | 2 | 12 | 0.002 |
| ICIQ-SF > 0 | 45 | 34 | |
| M (SD) | M (SD) | Change (95% CI) | |
| Total score | 13.40 (4.5) | 5.13 (4.5) | −8 (−10.0; −6.5) p value 0.000∗ |
Statistical tests: Student's t-test (variables with normal distribution) or Wilcoxon signed rank test (∗variables with nonnormal distribution); ∗∗McNemar.